26 results
8-K
EX-99.1
PYXS
Pyxis Oncology Inc
23 Aug 23
Pyxis Oncology Successfully Completes Acquisition of Apexigen
8:47am
completion of its acquisition of Apexigen, Inc. (“Apexigen”), a clinical-stage biopharmaceutical company focused on discovering and developing innovative
425
pqw5l1uamevy
25 May 23
Business combination disclosure
8:14am
425
qjp2pnv 3sflc7
24 May 23
Business combination disclosure
5:00pm
425
EX-99.1
5zcnumpi hx
24 May 23
Business combination disclosure
4:55pm
8-K
EX-99.1
0864nr81s9d imegb
24 May 23
Regulation FD Disclosure
4:53pm
425
0mcr2ehr
24 May 23
Business combination disclosure
7:05am
425
27mivkr8gku79qcn17
24 May 23
Business combination disclosure
7:03am
8-K
EX-99.1
4zig nyfe
24 May 23
Pyxis Oncology to Acquire Apexigen
6:59am
8-K
EX-99.1
xbxs n66d8u
15 Aug 22
Prioritized pipeline to focus on most advanced programs while maintaining financial flexibility to pursue business development opportunities
7:11am
10-K
rjydsqurizwep2
29 Mar 22
Annual report
7:36am
10-Q
zs18i4 i7stj
15 Nov 21
Quarterly report
7:54am
424B4
jqr4s z1q
8 Oct 21
Prospectus supplement with pricing info
5:00pm